# Oral Statins and Protection From Hearing Loss

> **NCT04826237** · PHASE4 · RECRUITING · sponsor: **Northwestern University** · enrollment: 100 (estimated)

## Conditions studied

- Sudden Sensorineural Hearing Loss

## Interventions

- **DRUG:** Statin
- **DRUG:** methylprednisolone
- **DRUG:** dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04826237
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-09
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826237, "Oral Statins and Protection From Hearing Loss". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04826237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*